{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T10:59:25Z","timestamp":1793876365535,"version":"4.7.0"},"reference-count":77,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Increasing evidence suggests that the onset and progression of primary biliary cholangitis (PBC) are closely linked to changes in gut microbiota, including bacterial translocation, molecular mimicry, and immune regulation. This study aimed to conduct a bibliometric analysis of the frontiers and hotspots of research on the relationship between gut microbiota and PBC between 2004 and 2024.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A bibliometric study was conducted by searching the Web of Science database for articles on intestinal flora and PBC published between 2004 and 2024. Excel, VOSviewer, and CiteSpace were used for econometric analysis and visualization of the identified articles.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Between 2004 and 2024, 167 articles focusing on intestinal flora and PBC were published. The number of publications in this field maintained an upward trend over the years, with China and the United States contributing the highest number of articles. The United States had the highest total number of citations, and the institution with the most publications in the United States was the University of California Davis, with the team led by Professor Gershwin contributing the greatest number of articles. <jats:italic>Frontiers in Immunology<\/jats:italic> had the highest number of articles in the field, while <jats:italic>Nature<\/jats:italic> had the highest impact in terms of publications in this area of research. The main keywords were \u201cprimary sclerosing cholangitis,\u201d \u201cbile acids,\u201d \u201cursodeoxycholic acid,\u201d \u201ccirrhosis,\u201d \u201cfarnesoid X receptor,\u201d \u201cinflammatory bowel disease,\u201d \u201crisk factors,\u201d and \u201cliver disease.\u201d<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>There is a correlation between gut microbiota and PBC, and the role of gut microbiota in the pathogenesis and treatment of PBC will continue to be a future research direction. Targets such as bile acids and farnesoid X receptors are also current research hotspots.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1565778","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T05:26:42Z","timestamp":1747805202000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Bibliometric analysis of research on intestinal flora and primary biliary cholangitis published between 2004 and 2024 using VOSviewer and CiteSpace visualization"],"prefix":"10.3389","volume":"12","author":[{"given":"Tao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"034","DOI":"10.1055\/s-0039-1697617","article-title":"The pathogenesis of primary biliary cholangitis: a comprehensive review","volume":"40","author":"Lleo","year":"2019","journal-title":"Semin Liver Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/hmed.2021.0450","article-title":"Primary biliary cholangitis: advances in understanding and management","volume":"83","author":"Smith","year":"2022","journal-title":"Br J Hosp Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.cld.2022.06.001","article-title":"Contemporary epidemiology of primary biliary cholangitis","volume":"26","author":"Colapietro","year":"2022","journal-title":"Clin Liver Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cld.2022.06.004","article-title":"Autoantibodies in primary biliary cholangitis","volume":"26","author":"Leung","year":"2022","journal-title":"Clin Liver Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.cld.2023.07.002","article-title":"Autoimmune markers in primary biliary cholangitis","volume":"28","author":"Shah","year":"2024","journal-title":"Clin Liver Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-021-10276-6","article-title":"APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis","volume":"16","author":"You","year":"2022","journal-title":"Hepatol Int."},{"key":"B7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41575-019-0226-7","article-title":"Primary biliary cholangitis: pathogenesis and therapeutic opportunities","volume":"17","author":"Gulamhusein","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.cld.2022.06.002","article-title":"Genetics of primary biliary cholangitis","volume":"26","author":"Gerussi","year":"2022","journal-title":"Clin Liver Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases","volume":"69","author":"Lindor","year":"2018","journal-title":"Hepatology."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e0179","DOI":"10.1097\/HC9.0000000000000179","article-title":"Primary biliary cholangitis: epidemiology, prognosis, and treatment","volume":"7","author":"Trivella","year":"2023","journal-title":"Hepatol Commun."},{"key":"B11","doi-asserted-by":"publisher","first-page":"958","DOI":"10.14218\/jcth.2022.00408","article-title":"Targeting gut microbiota for the treatment of primary biliary cholangitis: from bench to bedside","volume":"11","author":"Zhang","year":"2023","journal-title":"J Clin Transl Hepatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1111\/1462-2920.13401","article-title":"Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis","volume":"18","author":"Lv","year":"2016","journal-title":"Environ Microbiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1111\/liv.14153","article-title":"The gut microbial influence on cholestatic liver disease","volume":"39","author":"Kummen","year":"2019","journal-title":"Liver Int."},{"key":"B14","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3389\/fphar.2020.00842","article-title":"Knowledge mapping of drug-induced liver injury: a scientometric investigation (2010\u20132019)","volume":"11","author":"Ke","year":"2020","journal-title":"Front Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"942841","DOI":"10.3389\/fphar.2022.942841","article-title":"Treatment of Liver Fibrosis: A 20-Year Bibliometric and Knowledge-Map Analysis","volume":"13","author":"Dai","year":"2022","journal-title":"Front Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.3748\/wjg.v29.i24.3899","article-title":"Immunological factors in cirrhosis diseases from a bibliometric point of view","volume":"29","author":"Zhang","year":"2023","journal-title":"World J Gastroenterol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"392","DOI":"10.5195\/jmla.2022.1434","article-title":"VOSviewer and bibliometrix","volume":"110","author":"Arruda","year":"2022","journal-title":"J Med Libr Assoc."},{"key":"B18","doi-asserted-by":"publisher","first-page":"102339","DOI":"10.1016\/j.mex.2023.102339","article-title":"A method for analyzing text using VOSviewer","volume":"11","author":"Bukar","year":"2023","journal-title":"MethodsX."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1097\/JS9.0000000000001022","article-title":"Worldwide research trends on tumor burden and immunotherapy: a bibliometric analysis","volume":"110","author":"Zhang","year":"2024","journal-title":"Int J Surg."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1361439","DOI":"10.3389\/fmicb.2024.1361439","article-title":"Visual trends and hot research on the relationship between intestinal microbiota and major lipids: a bibliometric analysis","volume":"15","author":"Sun","year":"2024","journal-title":"Front Microbiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1194\/jlr.R054114","article-title":"Intestinal transport and metabolism of bile acids","volume":"56","author":"Dawson","year":"2015","journal-title":"J Lipid Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/19490976.2019.1674124","article-title":"Diversification of host bile acids by members of the gut microbiota","volume":"11","author":"Winston","year":"2019","journal-title":"Gut Microbes."},{"key":"B23","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41586-020-2396-4","article-title":"A metabolic pathway for bile acid dehydroxylation by the gut microbiome","volume":"582","author":"Funabashi","year":"2020","journal-title":"Nature."},{"key":"B24","doi-asserted-by":"publisher","first-page":"948314","DOI":"10.3389\/fimmu.2022.948314","article-title":"A bibliometric analysis of T cell and atherosclerosis","volume":"13","author":"Wei","year":"2022","journal-title":"Front Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/gutjnl-2016-313332","article-title":"Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy","volume":"67","author":"Tang","year":"2017","journal-title":"Gut."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1136\/gutjnl-2015-311004","article-title":"Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD","volume":"65","author":"Sabino","year":"2016","journal-title":"Gut."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1390483","DOI":"10.3389\/fphar.2024.1390483","article-title":"Global research trends on gut microbiota and metabolic dysfunction-associated steatohepatitis: Insights from bibliometric and scientometric analysis","volume":"15","author":"Alam","year":"2024","journal-title":"Front Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1118674","DOI":"10.3389\/fpubh.2023.1118674","article-title":"Global hotspots and trends in research on preschool children's motor development from 2012 to 2022: a bibliometric analysis","volume":"11","author":"Wang","year":"2023","journal-title":"Front Public Health."},{"key":"B29","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","article-title":"The gut\u2013liver axis and the intersection with the microbiome","volume":"15","author":"Tripathi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1053\/j.gastro.2024.01.049","article-title":"Immunopathogenesis of primary biliary cholangitis, primary sclerosing cholangitis and autoimmune hepatitis: themes and concepts","volume":"166","author":"Trivedi","year":"2024","journal-title":"Gastroenterology."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.autrev.2013.06.004","article-title":"Innate and adaptive immunity in inflammatory bowel disease","volume":"13","author":"Geremia","year":"2014","journal-title":"Autoimmun Rev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"733992","DOI":"10.3389\/fcimb.2022.733992","article-title":"The gut microbiota in inflammatory bowel disease","volume":"12","author":"Qiu","year":"2022","journal-title":"Front Cell Infect Microbiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/j.1572-0241.2006.00947.x","article-title":"Abnormal hepatic biochemistries in patients with inflammatory bowel disease","volume":"102","author":"Mendes","year":"2007","journal-title":"Am J Gastroenterol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"6137","DOI":"10.3748\/wjg.v23.i33.6137","article-title":"Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases","volume":"23","author":"Halling","year":"2017","journal-title":"World J Gastroenterol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fmed.2023.1320842","article-title":"Causal effects from inflammatory bowel disease on liver function and disease: a two-sample Mendelian randomization study","author":"Shu","year":"2024","journal-title":"Frontiers in Medicine."},{"key":"B36","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1146\/annurev-immunol-051116-052424","article-title":"Mucosal ecological network of epithelium and immune cells for gut homeostasis and tissue healing","volume":"35","author":"Kurashima","year":"2017","journal-title":"Annu Rev Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1042\/BST20201201","article-title":"Relationship between mucosa-associated gut microbiota and human diseases","volume":"50","author":"Juge","year":"2022","journal-title":"Biochem Soc Trans."},{"key":"B38","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1146\/annurev-immunol-032712-095948","article-title":"Tissue tregs","volume":"34","author":"Panduro","year":"2016","journal-title":"Annu Rev Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nri.2016.36","article-title":"Development and maintenance of intestinal regulatory T cells","volume":"16","author":"Tanoue","year":"2016","journal-title":"Nat Rev Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3389\/fimmu.2018.00883","article-title":"Emerging functions of regulatory T cells in tissue homeostasis","volume":"9","author":"Sharma","year":"2018","journal-title":"Front Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1097\/CM9.0000000000002291","article-title":"Intestinal homeostasis in autoimmune liver diseases","volume":"135","author":"Liu","year":"2022","journal-title":"Chinese Medical J."},{"key":"B42","doi-asserted-by":"publisher","first-page":"037","DOI":"10.1055\/s-0035-1571276","article-title":"Targeting dysbiosis for the treatment of liver disease","volume":"36","author":"Anand","year":"2016","journal-title":"Semin Liver Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-\u03b2 signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nat Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/cei.13198","article-title":"Pathogen infections and primary biliary cholangitis","volume":"195","author":"Tanaka","year":"2018","journal-title":"Clin Exp Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.3390\/ijms17091575","article-title":"Molecular Pathogenesis of NASH","volume":"17","author":"Caligiuri","year":"2016","journal-title":"Int J Mol Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e12191","DOI":"10.1371\/journal.pone.0012191","article-title":"High-Fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse","volume":"5","author":"Ding","year":"2010","journal-title":"PLoS ONE."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease\u2020","volume":"49","author":"Miele","year":"2009","journal-title":"Hepatology."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e9302","DOI":"10.15252\/emmm.201809302","article-title":"The role of the microbiome in NAFLD and NASH","volume":"11","author":"Kolodziejczyk","year":"2018","journal-title":"EMBO Molec Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"18017","DOI":"10.1038\/nrdp.2018.17","article-title":"Autoimmune hepatitis","volume":"4","author":"Mieli-Vergani","year":"2018","journal-title":"Nat Rev Dis Prim."},{"key":"B50","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jaut.2018.10.020","article-title":"Etiopathogenesis of autoimmune hepatitis","volume":"95","author":"Floreani","year":"2018","journal-title":"J Autoimmun."},{"key":"B51","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1159\/000444471","article-title":"The pathogenesis of autoimmune liver disease","volume":"34","author":"Arndtz","year":"2016","journal-title":"Digestive Diseases."},{"key":"B52","doi-asserted-by":"publisher","first-page":"947382","DOI":"10.3389\/fcimb.2022.947382","article-title":"The gut microbiota: a novel player in autoimmune hepatitis","volume":"12","author":"Cheng","year":"2022","journal-title":"Front Cell Infect Microbiol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","article-title":"Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4","volume":"21","author":"Dapito","year":"2012","journal-title":"Cancer Cell."},{"key":"B54","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev-nutr-082018-124344","article-title":"Bile acids as metabolic regulators and nutrient sensors","volume":"39","author":"Chiang","year":"2019","journal-title":"Annu Rev Nutr."},{"key":"B55","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/hep.28965","article-title":"The ascending pathophysiology of cholestatic liver disease","volume":"65","author":"Jansen","year":"2017","journal-title":"Hepatology."},{"key":"B56","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41575-021-00566-7","article-title":"Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology","volume":"19","author":"Fuchs","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13578-023-01035-1","article-title":"Bile acid-mediated signaling in cholestatic liver diseases","volume":"13","author":"Zeng","year":"2023","journal-title":"Cell Biosci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.jhep.2019.06.017","article-title":"Fxr modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis","volume":"71","author":"Sorribas","year":"2019","journal-title":"J Hepatol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring Fxr antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metab"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","article-title":"Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease","volume":"152","author":"Ch\u00e1vez-Talavera","year":"2017","journal-title":"Gastroenterology."},{"key":"B61","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3727\/105221618X15156018385515","article-title":"Bile acid metabolism in liver pathobiology","volume":"18","author":"Chiang","year":"2018","journal-title":"Gene Expr."},{"key":"B62","doi-asserted-by":"publisher","first-page":"9952","DOI":"10.3748\/wjg.v20.i29.9952","article-title":"Therapeutic uses of animal biles in traditional Chinese medicine: an ethnopharmacological, biophysical chemical and medicinal review","volume":"20","author":"Wang","year":"2014","journal-title":"World J Gastroenterol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/ncpgasthep0521","article-title":"Drug Insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis","volume":"3","author":"Beuers","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.apsb.2015.01.006","article-title":"The human gut sterolbiome: bile acid-microbiome endocrine aspects and therapeutics","volume":"5","author":"Ridlon","year":"2015","journal-title":"Acta Pharmaceutica Sinica B."},{"key":"B65","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.3390\/ijms25084321","article-title":"Exploring advanced therapies for primary biliary cholangitis: insights from the gut microbiota\u2013bile acid\u2013immunity network","volume":"25","author":"Guo","year":"2024","journal-title":"Int J Mol Sci."},{"key":"B66","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jhep.2017.05.009","article-title":"norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis","volume":"67","author":"Fickert","year":"2017","journal-title":"J Hepatol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"788558","DOI":"10.3389\/fphar.2021.788558","article-title":"Ursodeoxycholic acid treatment restores gut microbiota and alleviates liver inflammation in non-alcoholic steatohepatitic mouse model","volume":"12","author":"Li","year":"2021","journal-title":"Front Pharmacol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S2468-1253(21)00099-6","article-title":"Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy","volume":"6","author":"Black","year":"2021","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"G872","DOI":"10.1152\/ajpgi.00163.2019","article-title":"Ursodeoxycholic acid: a promising therapeutic target for inflammatory bowel diseases?","volume":"317","author":"Keely","year":"2019","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s13075-023-03163-y","article-title":"Integrative bioinformatics analysis and experimental validation of key biomarkers for risk stratification in primary biliary cholangitis","volume":"25","author":"Tian","year":"2023","journal-title":"Arthr Res Ther."},{"key":"B71","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N Engl J Med"},{"key":"B72","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.jhep.2017.01.013","article-title":"Steroidal or non-steroidal FXR agonists \u2013 Is that the question?","volume":"66","author":"Verbeke","year":"2017","journal-title":"J Hepatol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1053\/j.gastro.2018.08.022","article-title":"FXR-dependent modulation of the human small intestinal microbiome by the bile acid derivative obeticholic acid","volume":"155","author":"Friedman","year":"2018","journal-title":"Gastroenterol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1146\/annurev-pathol-030320-095722","article-title":"Gut microbiota in intestinal and liver disease","volume":"16","author":"Jones","year":"2021","journal-title":"Ann Rev Pathol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e23037","DOI":"10.1371\/journal.pone.0023037","article-title":"Gut microbiota dysbiosis is associated with inflammation and bacterial translocation in mice with CCl4-induced fibrosis","volume":"6","author":"G\u00f3mez-Hurtado","year":"2011","journal-title":"PLoS ONE."},{"key":"B76","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1053\/he.2000.5634","article-title":"Kupffer cell activation by lipopolysaccharide in rats: Role for lipopolysaccharide binding protein and toll-like receptor 4","volume":"31","author":"Su","year":"2000","journal-title":"Hepatology."},{"key":"B77","doi-asserted-by":"publisher","first-page":"7312","DOI":"10.3748\/wjg.v20.i23.7312","article-title":"Pathogenesis of liver cirrhosis","volume":"20","author":"Zhou","year":"2014","journal-title":"World J Gastroenterol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1565778\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T05:26:42Z","timestamp":1747805202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1565778\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":77,"alternative-id":["10.3389\/fmed.2025.1565778"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1565778","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"article-number":"1565778"}}